Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 8-K Event Delisting notice
  4. 8-K Event Executive or director change
  5. 4 Option exercise CEO and President acquired 350,000 shares (option exercise)
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Planned sale SVP, CFO, CBO & Treasurer sold 56,019 shares at $1.11 ($62,181)
  10. 8-K Event Regulation FD disclosure · Other events
  11. 144 Insider Sale of Securities
  12. 4 Grant or award Director acquired 35,700 shares (grant or award)
  13. 4 Grant or award Director acquired 35,700 shares (grant or award)
  14. 4 Grant or award Director acquired 35,700 shares (grant or award)
  15. 4 Grant or award Director acquired 35,700 shares (grant or award)
  16. 8-K Event Shareholder vote results
  17. 4 Grant or award Director acquired 35,700 shares (grant or award)
  18. 4 Grant or award Director acquired 35,700 shares (grant or award)
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. 10-Q Report Quarterly Report

Page 1 of 45 · 886 filings